Evidence map›Paper›PMID 35214519›Full record

ReviewSensors (Basel, Switzerland)2022

Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges.

Shih-Mo Yang, Shuangsong Lv, Wenjun Zhang, Yubao Cui

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Cardiac troponin sensingRSC advances · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shih-Mo YangSchool of Mechatronic Engineering and Automation, Shanghai University, Shanghai 200444, China.
Shuangsong LvSchool of Mechatronic Engineering and Automation, Shanghai University, Shanghai 200444, China.
Wenjun ZhangDivision of Biomedical Engineering, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada.ORCID 0000-0001-7973-8769
Yubao CuiClinical Research Center, The Affiliated Wuxi People's Hospital, Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, China.ORCID 0000-0001-7736-8012

Funding

the 333 project of Jiangsu Province in 2017, the Primary Research & Development Plan of Jiangsu Province, the Taihu Lake talent plan, the Complex and Intelligent Research Center, School of Mechanical and Power Engineering, East China University of Scien BRA2017216, BE2018627,2020THRC-GD-7, D18003, LM201603, KFKT2018001the National Natural Sciences Foundation of China NSFC81971511
6 · The paper itself

Abstract

The early diagnosis of infectious diseases is critical because it can greatly increase recovery rates and prevent the spread of diseases such as COVID-19; however, in many areas with insufficient medical facilities, the timely detection of diseases is challenging. Conventional medical testing methods require specialized laboratory equipment and well-trained operators, limiting the applicability of these tests. Microfluidic point-of-care (POC) equipment can rapidly detect diseases at low cost. This technology could be used to detect diseases in underdeveloped areas to reduce the effects of disease and improve quality of life in these areas. This review details microfluidic POC equipment and its applications. First, the concept of microfluidic POC devices is discussed. We then describe applications of microfluidic POC devices for infectious diseases, cardiovascular diseases, tumors (cancer), and chronic diseases, and discuss the future incorporation of microfluidic POC devices into applications such as wearable devices and telemedicine. Finally, the review concludes by analyzing the present state of the microfluidic field, and suggestions are made. This review is intended to call attention to the status of disease treatment in underdeveloped areas and to encourage the researchers of microfluidics to develop standards for these devices.

Indexed as

COVID-19Point-of-Care SystemsHumansLab-On-A-Chip DevicesMicrofluidicsQuality of LifeSARS-CoV-2COVID-19medical testingmicrofluidicPOC (point-of-care)telemedicinewearable devices

Identifiers

PMID35214519
PMCPMC8875995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.